As I and others have been saying all along, Valimed is in a small market as presently configured. It will never provide really significant revenue..even if it has "saved a life" or two. Sob stories are not a viable basis for sales.
Likewise, the Meth gun will be a niche market, if ever deployed.
Here the company sits, no money, no products that will ever generate a whole lot of revenue, and save the shareholders from loss.
The INONITs can make a dime or a dollar..lots of them, in fact. The shareholders are restricted to selling shares back and forth to each other, and the occaisional new sucker.